Pathstone Holdings
GH icon

Pathstone Holdings’s Guardant Health GH Stock Holding History

Pathstone Holdings’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.88M Buy
52,568
+476
+0.9% +$51.8K 0.02% 491
2026
Q1 		$4.81M Sell
52,092
-3,780
-7% -$380K 0.02% 582
2025
Q4 		$5.71M Buy
55,872
+5,234
+10% +$468K 0.02% 518
2025
Q3 		$3.16M Buy
50,638
+25,922
+105% +$1.41M 0.01% 770
2025
Q2 		$1.29M Buy
24,716
+17,119
+225% +$765K 0.01% 1257
2025
Q1 		$324K Buy
7,597
+423
+6% +$18.3K ﹤0.01% 1907
2024
Q4 		$232K Buy
+7,174
New +$202K ﹤0.01% 2097
2024
Q1 		– Sell
-8,052
Closed -$218K – 2321
2023
Q4 		$218K Buy
+8,052
New +$211K ﹤0.01% 2023

Other funds holding GH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Pathstone Holdings's GH Position: Q2 2026 in Review

Pathstone Holdings increased its Guardant Health (GH) stake by 0.91% in Q2 2026, buying an estimated $51.8K and bringing the position to 52,568 shares worth $7.88M. The position accounts for 0.02% of the portfolio, ranked #491.

Pathstone Holdings first reported a position in GH in Q4 2023 and has held it in 8 quarters since. 597 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Pathstone Holdings held 52,568 shares of Guardant Health worth $7.88M as of Q2 2026.
  • Pathstone Holdings bought 476 Guardant Health shares in Q2 2026, an estimated $51.8K.
  • Guardant Health made up 0.02% of Pathstone Holdings's portfolio in Q2 2026, its #491 holding.
  • Pathstone Holdings first reported a position in Guardant Health in Q4 2023 and has held it in 8 quarters since.
  • 597 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Pathstone Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.